Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Pereira 2009 Biochem J"

From Bioblast
Β 
(9 intermediate revisions by 6 users not shown)
Line 1: Line 1:
{{Publication
{{Publication
|title=Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, Da Silva WS, Almeida FC, Da Poian AT, Galina A (2009) Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem J 771-726.
|title=Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, Da Silva WS, Almeida FC, Da Poian AT, Galina A (2009) Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem J 417:717-26.
|info=[http://www.ncbi.nlm.nih.gov/pubmed/18945211 PMID:18945211]
|info=[http://www.ncbi.nlm.nih.gov/pubmed/18945211 PMID: 18945211 Open Access]
|authors=Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, Da Silva WS, Almeida FC, Da Poian AT, Galina A
|authors=Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, Da Silva WS, Almeida FC, Da Poian AT, Galina A
|year=2009
|year=2009
Line 11: Line 11:
respiration was observed in HepG2 cells treated with 3-BrPA only when incubated in glucose-supplemented medium, indicating that 3-BrPA induces mitochondrial proton leakage as well as blocking the electron transport system. The activity
respiration was observed in HepG2 cells treated with 3-BrPA only when incubated in glucose-supplemented medium, indicating that 3-BrPA induces mitochondrial proton leakage as well as blocking the electron transport system. The activity
of succinate dehydrogenase was inhibited by 70% by 3-BrPA treatment. These results suggest that the combined action of 3- BrPA on succinate dehydrogenase and on glycolysis, inhibiting steps downstream of the phosphorylation of glucose, play an important role in HepG2 cell death.
of succinate dehydrogenase was inhibited by 70% by 3-BrPA treatment. These results suggest that the combined action of 3- BrPA on succinate dehydrogenase and on glycolysis, inhibiting steps downstream of the phosphorylation of glucose, play an important role in HepG2 cell death.
|keywords=3-bromopyruvate, glycolysis, hepatocellular carcinoma, HepG2 cell, mitochondrion, oxygen consumption, tumour cell.
|keywords=3-bromopyruvate, Glycolysis, Hepatocellular carcinoma, HepG2 cell, Mitochondrion, Oxygen consumption, Tumour cell.
|mipnetlab=BR_Rio de Janeiro_Galina A, BR Rio de Janeiro Da Poian AT, BR Rio de Janeiro Institute Biomedical Chemistry
|mipnetlab=BR Rio de Janeiro Galina A, BR Rio de Janeiro Da Poian AT
}}
}}
{{Labeling
{{Labeling
|area=Respiration
|diseases=Cancer
|organism=Human
|tissues=Liver
|preparations=Intact cells, Permeabilized cells
|couplingstates=LEAK, ROUTINE, OXPHOS, ET
|pathways=S, ROX
|instruments=Oxygraph-2k
|instruments=Oxygraph-2k
|injuries=Cancer; Apoptosis; Cytochrome c
|organism=Human
|tissues=Hepatocyte; Liver
|preparations=Intact Cell; Cultured; Primary
}}
}}

Latest revision as of 15:36, 13 November 2017

Publications in the MiPMap
Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, Da Silva WS, Almeida FC, Da Poian AT, Galina A (2009) Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate. Biochem J 417:717-26.

Β» PMID: 18945211 Open Access

Pereira da Silva AP, El-Bacha T, Kyaw N, dos Santos RS, Da Silva WS, Almeida FC, Da Poian AT, Galina A (2009) Biochem J

Abstract: 3-BrPA (3-bromopyruvate) is an alkylating agent with antitumoral activity on hepatocellular carcinoma. This compound inhibits cellular ATP production owing to its action on glycolysis and oxidative phosphorylation; however, the specific metabolic steps and mechanisms of 3-BrPA action in human hepatocellular carcinomas, particularly its effects on mitochondrial energetics, are poorly understood. In the present study it was found that incubation of HepG2 cells with a low concentration of 3-BrPA for a short period (150 ΞΌMfor 30 min) significantly affected both glycolysis and mitochondrial respiratory functions. The activity of mitochondrial hexokinase was not inhibited by 150 ΞΌM 3-BrPA, but this concentration caused more than 70% inhibition of GAPDH (glyceraldehyde-3-phosphate dehydrogenase) and 3-phosphoglycerate kinase activities. Additionally, 3-BrPA treatment significantly impaired lactate production by HepG2 cells, even when glucose was withdrawn from the incubation medium. Oxygen consumption of HepG2 cells supported by either pyruvate/malate or succinate was inhibited when cells were preincubated with 3-BrPA in glucose-free medium. On the other hand, when cells were pre-incubated in glucose-supplemented medium, oxygen consumption was affected only when succinate was used as the oxidizable substrate. An increase in oligomycinindependent respiration was observed in HepG2 cells treated with 3-BrPA only when incubated in glucose-supplemented medium, indicating that 3-BrPA induces mitochondrial proton leakage as well as blocking the electron transport system. The activity of succinate dehydrogenase was inhibited by 70% by 3-BrPA treatment. These results suggest that the combined action of 3- BrPA on succinate dehydrogenase and on glycolysis, inhibiting steps downstream of the phosphorylation of glucose, play an important role in HepG2 cell death. β€’ Keywords: 3-bromopyruvate, Glycolysis, Hepatocellular carcinoma, HepG2 cell, Mitochondrion, Oxygen consumption, Tumour cell.

β€’ O2k-Network Lab: BR Rio de Janeiro Galina A, BR Rio de Janeiro Da Poian AT


Labels: MiParea: Respiration  Pathology: Cancer 

Organism: Human  Tissue;cell: Liver  Preparation: Intact cells, Permeabilized cells 


Coupling state: LEAK, ROUTINE, OXPHOS, ET  Pathway: S, ROX  HRR: Oxygraph-2k